Latest Spinal muscular atrophy Stories
Scientist from preclinical CRO, PharmOptima, presents new assay at the 2013 International SMA Research Group Meeting. Portage, MI (PRWEB) July 09, 2013
Stories of Hope, Success and Progress Illustrate Need for Collaboration With Patients Horsham, Pa.
StorageMart pledged to donate $1 for every pin in March and April of their "Pin for a Cure" image resulting in a $5,000 donation to the MDA. Columbia,
This program will assess the therapeutic potential of second-generation Antisense Oligonucleotides (ASO) sequences for SMA. This funding is being awarded to Co-Principal Investigators Dr.
There is no specific drug to treat spinal muscular atrophy (SMA), a family of motor neuron diseases that in its most severe form is the leading genetic cause of infant death in the United States and affects one in 6,000 people overall.
The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology (AAN), March 16-23, 2013, in San Diego.
- an ornament or knob in the shape of a flower